Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result

Scandinavian VC firm Sound Bioventures raises €110M for new biotherapeutics venture fund

Vishal Singh by Vishal Singh
January 4, 2022
in (Crowd)funding, News, Venture Capital
Sound Bioventures

Sound Bioventures' Founding Partner, Johan Kördel | Image credit: Sound Bioventures

LinkedInTwitterWhatsAppFacebook
Read this article in:

Scandinavia-based Sound Bioventures, a VC fund investing in about-to-be clinical or clinical stage private companies in Europe and US developing therapies in specialty therapeutics areas, announced the first close of its first fund at €110M.

The funding came from Novo Holdings, Saminvest, Vækstfonden, the European Investment Fund (EIF) and Ramsbury Invest, as well as the founders. 

The EIF investment was made possible under the European Guarantee Fund. The European Guarantee Fund (EGF) was set up by the EIB Group with contributions from Sweden and other EU Member States to support companies suffering from the COVID-19 crisis. 

Using nearly €25B in guarantees, the EGF enables the EIB and the EIF to make loans, guarantees, asset-backed securities, equity and other financial instruments available to mostly SMEs. The EGF is part of the European Union’s recovery package aiming to provide a total of €540B to boost those parts of the EU economy that have been hit the worst by the Covid-19 pandemic.

What to expect from the fund?

This first fund will focus on investing in European and US-based private biotech companies with assets in clinical or about-to-be-clinical stages in primarily orphan and rare diseases. The fund also intends to leverage Scandinavian science to build companies and facilitate cross-Atlantic exchange of innovation, sector knowledge and capital.

Alain Godard, Chief Executive at the European Investment Fund, says, “This EIF investment reflects the importance of supporting innovative players in this sector. Sound Bioventures has a strong founding team and the fund will be well-positioned to find and further develop companies that solve tomorrow’s health challenges.”

The fund will be managed by a founding team with venture investing and operational experience in drug development. They include Casper Breum, Johan Kördel, and Bibhash Mukhopadhyay. Casper has a back-ground from Novo Nordisk, Lundbeck and Lundbeckfonden Ventures, Johan from Pharmacia, Biovitrum and Lundbeckfonden Ventures, and Bibhash from J&J, Astra-Zeneca and NEA.

About Sound Bioventures

Sound Bioventures is a clinical-stage biotherapeutics-focused venture fund that has a foundation in the Nordic biotech ecosystem and will invest in the EU, UK, and the US. The firm’s Fund I AB is a registered alternative investment fund under the Swedish Alternative Investment Funds Managers Act. The target size for the fund is €150M.

The fund will seek opportunities to address significant unmet medical needs for new therapies. To date, the firm has made over 30 investments, many of which were in clinical stage rare/orphan disease companies.

Tags: featuredfundingnewsventure capital
ShareTweetSendShare

Partner content | Partner with us

Amsterdam’s Farmless raises €4.8M to free protein production from animals and agricultural land

Paris-based Echo Analytics acquires Amsterdam’s AI location firm Roam.ai: Here’s why

Meet Farhad Andalibi, a LinkedIn alumnus helping Techleap’s DLiT Community to advance DEI efforts in the Dutch tech ecosystem

Amsterdam’s Transferz joins forces with Holiday Extras to transform global ground transportation

ZVVT ignites tech movement for diversity in Amsterdam South-East district

Silicon Canals | Find a job

Top news | from Amsterdam

Check out the Amsterdam startups that raised funding in November; 5 of them are hiring

Amsterdam-based startups that are fundraising right now

Dutch-Swiss startup Cradle raises €21.9M for pioneering Generative AI in protein design

Germany’s Sastrify expands market reach; acquires Amsterdam-based Pengu and raises fresh funds

Amsterdam’s LAYCO raises €300K to make healthcare more sustainable and accessible

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Find a job
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • AI and chatbots
    • FinTech
    • Business Wire
    • Travel & Mobility
    • Coin Canals
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Amsterdam
    • Community partners
    • Remote: Tech Talent Report
    • Guest Contributions
  • Find a job
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Sign up for our newsletter!
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X